نتایج جستجو برای: کدون v57i aurka

تعداد نتایج: 1108  

Journal: :Pediatric blood & cancer 2013
Kleiton Silva Borges Daniel Antunes Moreno Carlos Eduardo Martinelli Sonir Roberto Rauber Antonini Margaret de Castro Silvio Tucci Luciano Neder Leandra Naira Zambelli Ramalho Ana Luiza Seidinger Izilda Cardinalli Maria José Mastellaro José Andres Yunes Silvia Regina Brandalise Luiz Gonzaga Tone Carlos Alberto Scrideli

BACKGROUND Pediatric adrenocortical tumors (ACT) are rare malignancies and treatment has a small impact on survival in advanced disease and the discovery of potential target genes could be important in new therapeutic approaches. METHODS The mRNA expression levels of spindle checkpoint genes AURKA, AURKB, BUB, and BUBR1 were analyzed in 60 children with ACT by quantitative real time PCR. The ...

2010
Jürgen den Hollander Sara Rimpi Joanne R. Doherty Martina Rudelius Andreas Buck Alexander Hoellein Marcus Kremer Nikolas Graf Markus Scheerer Mark A. Hall Andrei Goga Nikolas von Bubnoff Justus Duyster Christian Peschel John L. Cleveland Jonas A. Nilsson Ulrich Keller

Myc oncoproteins promote continuous cell growth, in part by controlling the transcription of key cell cycle regulators. Here, we report that c-Myc regulates the expression of Aurora A and B kinases (Aurka and Aurkb), and that Aurka and Aurkb transcripts and protein levels are highly elevated in Myc-driven B-cell lymphomas in both mice and humans. The induction of Aurka by Myc is transcriptional...

Journal: :Cancer medicine 2016
Jan Bornschein Jessica Nielitz Ignat Drozdov Michael Selgrad Thomas Wex Doerthe Jechorek Alexander Link Michael Vieth Peter Malfertheiner

Canonical Wnt signaling is involved in gastric carcinogenesis. The aim of this study was to identify the link between Wnt signaling and aurora kinase A (AURKA), a target for the treatment of gastrointestinal cancers. Publicly available microarray data were used to identify phenotype-specific protein-protein interaction (PPI) subnetworks. The in silico analysis revealed a gastric cancer-specific...

2018
Alexander Baumann Anna Maria S. Buchberger Guido Piontek Dominik Schüttler Martina Rudelius Rudolf Reiter Lena Gebel Gerhard Piendl Gero Brockhoff Anja Pickhard

Recently the Aurora-Kinases (Aurk) moved into the focus as novel disease related biomarkers and therapeutic targets. Elevated Aurora-Kinase expression has been found in a number of malignancies, amongst them HNSCC. For esophageal cancer, the AurkA Phe31-Ile polymorphism has previously been associated with tumor progression. Here we evaluated the treatment efficiency of HNSCC cell radiation as a...

2014
Sylvie Rouquier Marie-Jeanne Pillaire Christophe Cazaux Dominique Giorgi

BACKGROUND Colorectal and breast cancers are among the most common cancers worldwide. They result from a conjugated deficiency of gene maintenance and cell cycle control. OBJECTIVE We investigate the expression of the microtubule-associated protein MAP9/ASAP and its two partners AURKA and PLK1 in colorectal tumors as well as in ductal breast cancers. MATERIALS AND METHODS 26 colorectal canc...

Journal: :Neoplasia 2007
Noa Matarasso Anat Bar-Shira Uri Rozovski Serena Rosner Avi Orr-Urtreger

Overexpression of the centrosome-associated serine/threonine kinase Aurora Kinase A (AURKA) has been demonstrated in both advanced prostate cancer and high-grade prostatic intraepithelial neoplasia lesions. The single-nucleotide polymorphism T91A (Phe31Ile) has been implicated in AURKA overexpression and has been suggested as a low-penetrance susceptibility allele in multiple human cancers, inc...

2016
Yung Chang Hsu Mohane Selvaraj Coumar Wen-Chieh Wang Hui-Yi Shiao Yi-Yu Ke Wen-Hsing Lin Ching-Chuan Kuo Chun-Wei Chang Fu-Ming Kuo Pei-Yi Chen Sing-Yi Wang An-Siou Li Chun-Hwa Chen Po-Chu Kuo Ching-Ping Chen Ming-Hsine Wu Chen-Lung Huang Kuei-Jung Yen Yun-I Chang John T.-A. Hsu Chiung-Tong Chen Teng-Kuang Yeh Jen-Shin Song

The design and synthesis of a quinazoline-based, multi-kinase inhibitor for the treatment of acute myeloid leukemia (AML) and other malignancies is reported. Based on the previously reported furanopyrimidine 3, quinazoline core containing lead 4 was synthesized and found to impart dual FLT3/AURKA inhibition (IC50 = 127/5 nM), as well as improved physicochemical properties. A detailed structure-...

Journal: :Frontiers in oncology 2015
Italia Anna Asteriti Fabiola De Mattia Giulia Guarguaglini

The Aurora kinase A (AURKA) is involved in different aspects of mitotic control, from mitotic entry to cytokinesis. Consistent with its pleiotropic roles, several AURKA interactors are able to modulate its activity, the best characterized being the microtubule-binding protein TPX2, the centrosomal protein Cep192, and Bora. Bora has been described as an essential cofactor of AURKA for phosphoryl...

2015
Anna S. Nikonova Alexander Y. Deneka Louisa Eckman Meghan C. Kopp Harvey H. Hensley Brian L. Egleston Erica A. Golemis

Aurora-A kinase (AURKA) overexpression in numerous tumors induces aneuploidy, in part because of cytokinetic defects. Alisertib and other small-molecule inhibitors targeting AURKA are effective in some patients as monotherapies or combination therapies. Epidermal growth factor receptor (EGFR) pro-proliferative signaling activity is commonly elevated in cancer, and the EGFR inhibitor erlotinib i...

2017
Thuy-Vy Do Jeff Hirst Stephen Hyter Katherine F. Roby Andrew K. Godwin

Ovarian cancer is usually diagnosed at late stages when cancer has spread beyond the ovary and patients ultimately succumb to the development of drug-resistant disease. There is an urgent and unmet need to develop therapeutic strategies that effectively treat ovarian cancer and this requires a better understanding of signaling pathways important for ovarian cancer progression. Aurora A kinase (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید